Gastroesophageal Junction Adenocarcinoma Therapeutics Market

Key Players

  • Amgen
  • Astellas Pharma Inc
  • BlackRock
  • Bayer
  • BeiGene
  • Bristol-Myers Squibb
  • Daiichi Sankyo Company
  • Elevar Therapeutics
  • Eli Lilly and Company
  • FivePrime Therapeutics
  • Incyte Corporation
  • MacroGenics Inc
  • Merck KGaA
  • Novartis
  • Ono Pharmaceuticals
  • The Vanguard Group
  • Taiho Pharmaceutical Co. Ltd
  • Zai Labs
  • ZymeWorks
Future Market Insights

Gastroesophageal Junction Adenocarcinoma Therapeutics Market